WAY-131256 is an orally active, efficacious, and in vivo functionally selective M1 agonist: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents
Gespeichert in:
| Veröffentlicht in: | Drug development research 1997, Vol.40 (2), p.185-192 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 192 |
|---|---|
| container_issue | 2 |
| container_start_page | 185 |
| container_title | Drug development research |
| container_volume | 40 |
| creator | SABB, A. L STEIN, R. P MORRIS, H SAILER, T MOYER, J. A ABOU-GHARBIA, M HO, D. M VOGEL, R. L TASSE, R AMBURN, S FAIRMAN, D. K KOWAL, D MALHOTRA, D BOAST, C. A BARTOLOMEO, A |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_2760947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2760947</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_27609473</originalsourceid><addsrcrecordid>eNqNy70KwjAUhuEgCtafeziDo4UkrbYZRRQXN0F0kUNM5EhMpEcL3r0iXoDTN7zP1xGZkqbOtTamKzKpK52XhVF9MWC-SqlUWdeZOO4Xh1wVSs_mQAwYITUYwgvQPqh1U3Dek0VL6cnTTz4DRWipTeCf8UNS_Gp2wX0PsFWAlxSJHyPR8xjYjX87FJP1arfc5Hdki8E3GC3x6d7QDZvXSVdzacqq-JO9AY7XQ6s</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>WAY-131256 is an orally active, efficacious, and in vivo functionally selective M1 agonist: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>SABB, A. L ; STEIN, R. P ; MORRIS, H ; SAILER, T ; MOYER, J. A ; ABOU-GHARBIA, M ; HO, D. M ; VOGEL, R. L ; TASSE, R ; AMBURN, S ; FAIRMAN, D. K ; KOWAL, D ; MALHOTRA, D ; BOAST, C. A ; BARTOLOMEO, A</creator><creatorcontrib>SABB, A. L ; STEIN, R. P ; MORRIS, H ; SAILER, T ; MOYER, J. A ; ABOU-GHARBIA, M ; HO, D. M ; VOGEL, R. L ; TASSE, R ; AMBURN, S ; FAIRMAN, D. K ; KOWAL, D ; MALHOTRA, D ; BOAST, C. A ; BARTOLOMEO, A</creatorcontrib><identifier>ISSN: 0272-4391</identifier><identifier>EISSN: 1098-2299</identifier><identifier>CODEN: DDREDK</identifier><language>eng</language><publisher>Brisbane: Wiley-Liss</publisher><subject>Biological and medical sciences ; Medical sciences ; Neuropharmacology ; Neuroprotective agent ; Pharmacology. Drug treatments</subject><ispartof>Drug development research, 1997, Vol.40 (2), p.185-192</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2760947$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>SABB, A. L</creatorcontrib><creatorcontrib>STEIN, R. P</creatorcontrib><creatorcontrib>MORRIS, H</creatorcontrib><creatorcontrib>SAILER, T</creatorcontrib><creatorcontrib>MOYER, J. A</creatorcontrib><creatorcontrib>ABOU-GHARBIA, M</creatorcontrib><creatorcontrib>HO, D. M</creatorcontrib><creatorcontrib>VOGEL, R. L</creatorcontrib><creatorcontrib>TASSE, R</creatorcontrib><creatorcontrib>AMBURN, S</creatorcontrib><creatorcontrib>FAIRMAN, D. K</creatorcontrib><creatorcontrib>KOWAL, D</creatorcontrib><creatorcontrib>MALHOTRA, D</creatorcontrib><creatorcontrib>BOAST, C. A</creatorcontrib><creatorcontrib>BARTOLOMEO, A</creatorcontrib><title>WAY-131256 is an orally active, efficacious, and in vivo functionally selective M1 agonist: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents</title><title>Drug development research</title><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neuroprotective agent</subject><subject>Pharmacology. Drug treatments</subject><issn>0272-4391</issn><issn>1098-2299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqNy70KwjAUhuEgCtafeziDo4UkrbYZRRQXN0F0kUNM5EhMpEcL3r0iXoDTN7zP1xGZkqbOtTamKzKpK52XhVF9MWC-SqlUWdeZOO4Xh1wVSs_mQAwYITUYwgvQPqh1U3Dek0VL6cnTTz4DRWipTeCf8UNS_Gp2wX0PsFWAlxSJHyPR8xjYjX87FJP1arfc5Hdki8E3GC3x6d7QDZvXSVdzacqq-JO9AY7XQ6s</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>SABB, A. L</creator><creator>STEIN, R. P</creator><creator>MORRIS, H</creator><creator>SAILER, T</creator><creator>MOYER, J. A</creator><creator>ABOU-GHARBIA, M</creator><creator>HO, D. M</creator><creator>VOGEL, R. L</creator><creator>TASSE, R</creator><creator>AMBURN, S</creator><creator>FAIRMAN, D. K</creator><creator>KOWAL, D</creator><creator>MALHOTRA, D</creator><creator>BOAST, C. A</creator><creator>BARTOLOMEO, A</creator><general>Wiley-Liss</general><scope>IQODW</scope></search><sort><creationdate>1997</creationdate><title>WAY-131256 is an orally active, efficacious, and in vivo functionally selective M1 agonist</title><author>SABB, A. L ; STEIN, R. P ; MORRIS, H ; SAILER, T ; MOYER, J. A ; ABOU-GHARBIA, M ; HO, D. M ; VOGEL, R. L ; TASSE, R ; AMBURN, S ; FAIRMAN, D. K ; KOWAL, D ; MALHOTRA, D ; BOAST, C. A ; BARTOLOMEO, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_27609473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neuroprotective agent</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SABB, A. L</creatorcontrib><creatorcontrib>STEIN, R. P</creatorcontrib><creatorcontrib>MORRIS, H</creatorcontrib><creatorcontrib>SAILER, T</creatorcontrib><creatorcontrib>MOYER, J. A</creatorcontrib><creatorcontrib>ABOU-GHARBIA, M</creatorcontrib><creatorcontrib>HO, D. M</creatorcontrib><creatorcontrib>VOGEL, R. L</creatorcontrib><creatorcontrib>TASSE, R</creatorcontrib><creatorcontrib>AMBURN, S</creatorcontrib><creatorcontrib>FAIRMAN, D. K</creatorcontrib><creatorcontrib>KOWAL, D</creatorcontrib><creatorcontrib>MALHOTRA, D</creatorcontrib><creatorcontrib>BOAST, C. A</creatorcontrib><creatorcontrib>BARTOLOMEO, A</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Drug development research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SABB, A. L</au><au>STEIN, R. P</au><au>MORRIS, H</au><au>SAILER, T</au><au>MOYER, J. A</au><au>ABOU-GHARBIA, M</au><au>HO, D. M</au><au>VOGEL, R. L</au><au>TASSE, R</au><au>AMBURN, S</au><au>FAIRMAN, D. K</au><au>KOWAL, D</au><au>MALHOTRA, D</au><au>BOAST, C. A</au><au>BARTOLOMEO, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>WAY-131256 is an orally active, efficacious, and in vivo functionally selective M1 agonist: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents</atitle><jtitle>Drug development research</jtitle><date>1997</date><risdate>1997</risdate><volume>40</volume><issue>2</issue><spage>185</spage><epage>192</epage><pages>185-192</pages><issn>0272-4391</issn><eissn>1098-2299</eissn><coden>DDREDK</coden><cop>Brisbane</cop><cop>New York, NY</cop><cop>Chichester</cop><pub>Wiley-Liss</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0272-4391 |
| ispartof | Drug development research, 1997, Vol.40 (2), p.185-192 |
| issn | 0272-4391 1098-2299 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_2760947 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Biological and medical sciences Medical sciences Neuropharmacology Neuroprotective agent Pharmacology. Drug treatments |
| title | WAY-131256 is an orally active, efficacious, and in vivo functionally selective M1 agonist: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T01%3A59%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=WAY-131256%20is%20an%20orally%20active,%20efficacious,%20and%20in%20vivo%20functionally%20selective%20M1%20agonist:%20Challenges%20and%20opportunities%20for%20developing%20muscarinic%20receptor%20subtype-based%20therapeutic%20agents&rft.jtitle=Drug%20development%20research&rft.au=SABB,%20A.%20L&rft.date=1997&rft.volume=40&rft.issue=2&rft.spage=185&rft.epage=192&rft.pages=185-192&rft.issn=0272-4391&rft.eissn=1098-2299&rft.coden=DDREDK&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E2760947%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |